By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Valentis, Inc. 

863A Mitten Road

Burlingame  California  94010  U.S.A.
Phone: 650-697-1900 Fax: 650-652-1990



Gene Therapy

Company News
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. (VLTS) Announces Name Change and New Stock Symbol 7/30/2007 12:06:32 PM
Urigen N.A. Completes Reverse Merger With Valentis, Inc. (VLTS) 7/16/2007 11:44:37 AM
Valentis, Inc. (VLTS) Announces Temporary Adjournment of Annual Meeting of Stockholders Until July 12, 2007 6/29/2007 11:46:02 AM
Valentis, Inc. (VLTS)'s Common Stock to be Quoted on the NASD's Over-The-Counter Bulletin Board 6/21/2007 11:44:37 AM
Valentis, Inc. (VLTS) Announces Effectiveness of Registration Statement for the Proposed Merger With Urigen N.A. 6/12/2007 2:24:36 PM
Valentis, Inc. (VLTS) Receives NASDAQ Delisting Notice 5/18/2007 12:48:22 PM
Valentis, Inc. (VLTS) Announces Third Quarter Fiscal 2007 Financial Results and Provides Listing Update 5/16/2007 12:41:13 PM
Valentis, Inc. (VLTS) Receives Nasdaq Additional Staff Determination 2/28/2007 11:00:33 AM
Valentis, Inc. (VLTS) Announces Second Quarter Fiscal 2007 Financial Results 2/15/2007 11:25:42 AM
Valentis, Inc. (VLTS) And Urigen N.A. Announce The Filing Of A Registration Statement Relating To Their Proposed Merger Transaction 2/7/2007 3:11:45 PM